Daily Cosmetic Research Analysis
Analyzed 23 papers and selected 3 impactful papers.
Summary
A head-to-head randomized trial shows magnetic seed localization is noninferior to radioguided localization for nonpalpable breast lesions, with shorter hospital stay and cost savings but more hematomas. Two large meta-analyses update practice: colophonium contact allergy prevalence in dermatitis patients is 3.54%, and transoral endoscopic thyroidectomy (TOETVA) offers oncologic outcomes comparable to open surgery with superior cosmetic results at the expense of longer operative time.
Research Themes
- Wire-free, minimally invasive localization in breast-conserving surgery
- Scarless endocrine surgery with cosmetic outcome optimization
- Cosmetic-related contact allergens and population burden
Selected Articles
1. A Prospective Randomized Trial Comparing Radioguided Occult Lesion Localization (ROLL) and Magnetic Seed Localization for the Localization of Nonpalpable Breast Lesions: Analysis of Surgical Outcomes, Patient's Perception, and Costs.
In a single-center RCT (n=260), magnetic seed localization was noninferior to ROLL for negative margins, with identical resection ratios and similar complication rates but more hematomas. MSL shortened hospital stay and was cost-saving across subgroups, supporting wire-free adoption in breast-conserving surgery.
Impact: Provides high-quality randomized evidence with surgical, patient-reported, and economic outcomes, directly informing the choice of localization technique in breast-conserving surgery.
Clinical Implications: MSL can be considered a first-line wire-free option when radiotracer logistics are limiting, with counseling on higher hematoma risk and protocols to mitigate it; institutions may realize shorter stays and cost savings.
Key Findings
- Margin negativity: ROLL 97.7% vs MSL 93.1% (p=0.14), meeting noninferiority.
- Calculated resection ratio identical at 1.7 (p=0.61).
- Overall complications similar (6.2% MSL vs 4.7% ROLL, p=0.59); postlocalization hematoma higher with MSL (17% vs 7%, p=0.01).
- Hospital stay shorter with MSL (median 1 vs 2 days, p=0.001).
- MSL was cost-saving across all analyzed subgroups; most EQ-5D-5L domains similar except 'usual activities' favoring ROLL.
Methodological Strengths
- Prospective randomized noninferiority design with a clear primary endpoint.
- Includes patient-reported outcomes and cost analysis alongside surgical metrics.
Limitations
- Single-center design limits generalizability.
- Lack of blinding and perioperative focus without long-term follow-up.
Future Directions: Multicenter, longer-term RCTs should assess cosmetic outcomes, reoperation, and hematoma mitigation strategies; implementation studies can evaluate workflow and equity impacts.
BACKGROUD: Accurate localization of nonpalpable breast lesions in breast-conserving surgery (BCS) is essential for achieving oncological radicality, preserving cosmetic outcomes, and reducing reinterventions for positive margins. Radioguided occult lesion localization (ROLL) and magnetic seed localization (MSL) are established alternatives to wire-guided methods, but comparative evidence remains limited. METHODS: This prospective, single-centre, randomized clinical trial evaluated the noninferiority of MSL compared with ROLL in achieving negative surgical margins, assessed surgical, organizational, and patient-reported outcomes, and included a costs analysis. A total of 260 women with nonpalpable breast lesions suitable for BCS were enrolled between June 2023 and July 2025 and randomized 1:1 to ROLL or MSL. The primary endpoint was margin negativity. Secondary endpoints included calculated resection ratio (CRR), operative time, complications, hospital stay, reoperation rate, and EQ-5D-5L patient-reported outcomes. RESULTS: Negative margins were achieved in 97.7% of ROLL and 93.1% of MSL cases (p = 0.14), confirming MSL noninferiority. Median CRR was identical (1.7, p = 0.61). Overall complication rates were comparable (6.2%-MSL vs. 4.7%-ROLL, p = 0.59), although postlocalization hematoma was more frequent with MSL (17% vs. 7%, p = 0.01). Hospital stay was significantly shorter with MSL (1 vs. 2 days, p = 0.001). Operative times were similar, and surgeon experience did not influence margin status, although attendings achieved lower CRR with ROLL. EQ-5D-5L scores were comparable except for "usual activities" dimension, which favoured ROLL. CONCLUSIONS: MSL was noninferior to ROLL, with comparable safety and patient-reported outcomes. Magnetic seed localization was found to be costs-saving across all analysed subgroups. Our results show that MSL is an effective alternative for lesion localization in BCS.
2. Prevalence of Contact Allergy to Colophonium in Dermatitis Patients: A Systematic Review and Meta-Analysis.
Across 73 studies (n=459,757), the pooled prevalence of colophonium (rosin) contact allergy among dermatitis patients was 3.54% (95% CI 3.01–4.16), exceeding prior estimates. Given its presence in cosmetics and medical devices, this updated burden supports vigilant patch testing and exposure avoidance.
Impact: This large-scale meta-analysis refines current prevalence estimates, directly informing patch-test series composition and regulatory risk assessment for consumer and cosmetic products.
Clinical Implications: Clinicians should maintain high suspicion for rosin allergy in dermatitis, ensure patch testing includes colophonium, and counsel on avoidance of implicated cosmetics/adhesives; public health and industry can leverage these data for labeling and formulation changes.
Key Findings
- Included 73 studies with 459,757 dermatitis patients.
- Pooled prevalence of colophonium contact allergy was 3.54% (95% CI 3.01–4.16).
- Colophonium is widely used in medical devices and cosmetic products, underscoring exposure risk.
Methodological Strengths
- Very large pooled sample size enhances precision of prevalence estimates.
- Independent dual-database searches and proportion meta-analysis approach.
Limitations
- Heterogeneity among studies and patch-testing protocols likely substantial.
- Clinic-based dermatitis populations may limit generalizability to the general public.
Future Directions: Stratified analyses by geography, age, and product categories; trend analyses over time; evaluation of labeling/policy impacts on prevalence.
Colophonium is present in many consumer and industrial products, including medical devices and cosmetic products. Due to its extensive use, there is an inherent risk of developing a contact allergy to it. Previous studies have shown that the prevalence rate of contact allergy to colophonium is around 1%-2%. This meta-analysis aimed to estimate the current prevalence of colophonium contact allergy in dermatitis patients. Two authors independently searched PubMed, Embase and Web of Science for studies reporting the prevalence of contact allergy in dermatitis patients with inception through 30 June 2025. A proportion meta-analysis was conducted to estimate the pooled prevalence of colophonium contact allergy. Seventy-three studies involving 459 757 patients with dermatitis were included. The pooled prevalence of colophonium contact allergy was 3.54% (95% CI, 3.01-4.16) with an I
3. Transoral endoscopic thyroidectomy vestibular approach versus open thyroidectomy in surgical resection of the thyroid: a systematic review and meta-analysis.
Across 22 studies (n=4,397), TOETVA had longer operative time and higher drainage but matched open surgery on blood loss, lymph node metrics, and key complications, while improving cosmetic outcomes. Findings support offering scarless thyroidectomy to selected patients with appropriate expertise.
Impact: Synthesizes comparative safety, oncologic adequacy, and cosmetic benefit of TOETVA, informing patient selection and surgical counseling for minimally invasive, scarless thyroidectomy.
Clinical Implications: TOETVA can be offered to patients prioritizing cosmesis without compromising oncologic metrics; counsel about longer operative times and drainage, ensure institutional expertise and protocols.
Key Findings
- Included 22 studies with 4,397 patients comparing TOETVA vs open thyroidectomy.
- TOETVA had significantly longer operative time and higher drainage volume.
- No significant differences in blood loss, central lymph node retrieval, metastatic node yield, recurrent laryngeal nerve palsy, seroma, or wound infection.
- Conclusion: TOETVA is safe and feasible with comparable oncologic outcomes and superior cosmetic results.
Methodological Strengths
- Comprehensive multi-database search including RCTs, cohort, and retrospective studies.
- Standardized effect size calculations (SMDs, ORs with 95% CIs) using RevMan.
Limitations
- Heterogeneity likely due to mixed designs and learning-curve effects.
- Limited number of high-quality RCTs; cosmetic outcomes not uniformly quantified.
Future Directions: Well-powered multicenter RCTs with standardized cosmetic/quality-of-life metrics and long-term recurrence data; learning-curve and cost-effectiveness analyses.
BACKGROUND: The increasing incidence of thyroid nodules and thyroid cancer, particularly among women, has driven the evolution of minimally invasive thyroidectomy techniques. The transoral endoscopic thyroidectomy vestibular approach (TOETVA) has emerged as a promising alternative to conventional open thyroidectomy (OT). This study aimed to compare operative time, blood loss, drainage volume, lymph node yield, and postoperative complications between TOETVA and OT. METHODS: A comprehensive search was conducted across PubMed, Embase, ClinicalTrials.gov, and Web of Science. Randomized controlled trials, cohort studies, and retrospective studies comparing TOETVA and OT were included. Statistical analysis was performed using RevMan version 5.3. Standardized mean differences and odds ratios with 95% confidence intervals were calculated. A RESULTS: A total of 22 studies involving 4397 patients were included. TOETVA was associated with a significantly longer operative time and higher drainage volume. However, no significant differences were observed in blood loss, number of retrieved central lymph nodes, metastatic lymph node yield, recurrent laryngeal nerve palsy, seroma formation, or wound infection. CONCLUSION: TOETVA represents a safe and feasible alternative to OT, offering comparable surgical and oncological outcomes with the added benefit of superior cosmetic results.